Stock TOI THE ONCOLOGY INSTITUTE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings The Oncology Institute, Inc.

Equities

TOI

US68236X1000

End-of-day quote Nasdaq
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
0.4942 USD +4.99% Intraday chart for The Oncology Institute, Inc. -5.87% -75.77%
May. 14 Transcript : The Oncology Institute, Inc., Q1 2024 Earnings Call, May 14, 2024
May. 14 The Oncology Institute, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Strengths

  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • Low profitability weakens the company.
  • Over the past four months, analysts' average price target has been revised downwards significantly.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
THE ONCOLOGY INSTITUTE, INC. Stock The Oncology Institute, Inc.
-75.77% 36.79M - -
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+25.52% 88.99B
C+
CVS HEALTH CORPORATION Stock CVS Health Corporation
-24.52% 74.82B
B-
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
-4.23% 25.03B
C+
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+4.31% 17.88B
A-
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-14.25% 16.43B
B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+2.97% 15.77B
A-
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+79.20% 13.21B
C+
NATERA, INC. Stock Natera, Inc.
+70.11% 13.08B
C-
DAVITA INC. Stock DaVita Inc.
+40.44% 12.9B
B-
Investor Rating
-
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision
-

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. TOI Stock
  4. Ratings The Oncology Institute, Inc.